Oncología Hepática
Seoul National University Hospital
Seúl, Corea del SurPublicaciones en colaboración con investigadores/as de Seoul National University Hospital (4)
2023
-
Robotic versus laparoscopic liver resection for huge (â¥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases
HEPATOBILIARY SURGERY AND NUTRITION, Vol. 12, Núm. 2, pp. 205-216
-
Robotic versus laparoscopic liver resection for huge (â¥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases
HEPATOBILIARY SURGERY AND NUTRITION, Vol. 12, Núm. 2, pp. 205-216
2021
-
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Journal of Clinical Oncology, Vol. 39, Núm. 27, pp. 2991-3001
2017
-
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
The Lancet, Vol. 389, Núm. 10088, pp. 2492-2502